Humane Genomics
YC S21New York City, US · Founded 2019 · 5 employees · 14 known investors
Find your way into Humane Genomics
Sign up to see every warm intro you have to Humane Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Humane Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
Founders & leadership· Y Combinator alumni (S21)
Humane Genomics was founded in 2019 by Peter Weijmarshausen and Chad Moles.


Investors · 14
How we know: 2048 Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · gaingels.com · Not right? Tell us
How we know: Humba Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: Leo Capital Ventures's portfolio page · Not right? Tell us
How we know: LifeX Ventures's portfolio page · Not right? Tell us
How we know: Red Beard Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Union Square Ventures (USV)'s portfolio page · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeedFeb 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 7
Companies working in the same space as Humane Genomics.
Legal entities · 1
corporate structureIn the news
Frequently asked questions
- What does Humane Genomics do?
- Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.
- Who founded Humane Genomics?
- Humane Genomics was founded by Peter Weijmarshausen, Chad Moles in 2019.
- Who are Humane Genomics's investors?
- Humane Genomics's investors include 2048 Ventures, Gaingels, Humba Ventures, Leo Capital Ventures, LifeX Ventures, Mana Ventures, Red Beard Ventures, Union Square Ventures (USV) and 6 more.
- Where is Humane Genomics headquartered?
- Humane Genomics is headquartered in New York City, US.


__Twitter.png)
.jpeg)












